Key result
Injection of CaMKII inhibitory peptide into mouse skeletal muscle fibers decreased tetanic free myoplasmic [Ca(2+)] by approximately 25%, indicating CaMKII facilitates SR Ca(2+) release.
Why the study?
Does CaMKII inhibition reduce sarcoplasmic reticulum Ca2+ release in mouse skeletal muscle fibers?
Does CaMKII inhibition reduce sarcoplasmic reticulum Ca2+ release in mouse skeletal muscle fibers?
CaMKII-induced phosphorylation facilitates sarcoplasmic reticulum Ca2+ release in the basal state and during repeated contractions in mouse skeletal muscle.
Answers are grounded in this paper and cite their sources.
CaMKII inhibition may impair skeletal muscle Ca2+ release; hypothesis-generating for human cardiac applications and requires validation.
Activation of the contractile machinery in skeletal muscle is initiated by the action-potential-induced release of Ca(2+) from the sarcoplasmic reticulum (SR). Several proteins involved in SR Ca(2+) release are affected by calmodulin kinase II (CaMKII)-induced phosphorylation in vitro, but the effect in the intact cell remains uncertain and is the focus of the present study. CaMKII inhibitory peptide or inactive control peptide was injected into single isolated fast-twitch fibres of mouse flexor digitorum brevis muscles, and the effect on free myoplasmic [Ca(2+)] ([Ca(2+)](i)) and force during different patterns of stimulation was measured. Injection of the inactive control peptide had no effect on any of the parameters measured. Conversely, injection of CaMKII inhibitory peptide decreased tetanic [Ca(2+)](i) by ≈25 %, but had no significant effect on the rate of SR Ca(2+) uptake or the force-[Ca(2+)](i) relationship. Repeated tetanic stimulation resulted in increased tetanic [Ca(2+)](i), and this increase was smaller after CaMKII inhibition. In conclusion, CaMKII-induced phosphorylation facilitates SR Ca(2+) release in the basal state and during repeated contractions, providing a positive feedback between [Ca(2+)](i) and SR Ca(2+) release.
No takes yet. Share an insight, caveat, or question.
Tavi et al. (2003) studied Mouse skeletal muscle physiology. CaMKII inhibitory peptide vs. Inactive control peptide was evaluated on Free myoplasmic [Ca(2+)](i) and force during different patterns of stimulation. Injection of CaMKII inhibitory peptide into mouse skeletal muscle fibers decreased tetanic free myoplasmic [Ca(2+)] by approximately 25%, indicating CaMKII facilitates SR Ca(2+) release.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: